NCT01992367View on ClinicalTrials.gov

Phase 1, Randomised Double Blinded Placebo Controlled Study of ASLAN003

PHASE1CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Healthy Volunteers
Interventions
DRUG

ASLAN003 ACTIVE

This is a single-centre, placebo-controlled, randomised, double-blind study involving SAD and MAD of ASLAN003 in healthy subjects.

Trial Locations (1)

Unknown

Singapore

Sponsors
All Listed Sponsors
lead

ASLAN Pharmaceuticals

OTHER